Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sarcoplasmic reticulum (SR) calcium release is the process by which calcium ions (Ca2+) are released from the sarcoplasmic reticulum, a specialized organelle in muscle cells. This release is crucial for initiating muscle contraction in skeletal, cardiac, and smooth muscle. The SR acts as an intracellular store of Ca2+, and upon stimulation, Ca2+ is rapidly released into the cytoplasm through ryanodine receptors (RyRs). After contraction, Ca2+ is actively pumped back into the SR by SERCA pumps, allowing relaxation. Dysregulation of SR calcium release can lead to various diseases, including heart failure, malignant hyperthermia, and Brody disease.
Modulation of calcium release channels (RyRs) or calcium reuptake pumps (SERCA) to influence muscle contractility.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sarcoplasmic Reticulum Calcium Release (SR Calcium Release).